Navigation Links
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Date:10/24/2011

DES PLAINES, Ill., Oct. 24, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults.

Abbott's Vysis EGR1 FISH Probe Kit, the third Abbott FISH assay approved or cleared in the past two months by the FDA for oncology applications, detects a chromosomal deletion in bone marrow that is usually associated with an unfavorable prognosis for AML patients.  In AML, fast-growing abnormal white blood cells in bone marrow replace healthy cells and impede the body's ability to fight infection.  Eventually, the bone marrow ceases to function properly, leaving patients infection-prone and at risk for bleeding.  More than 12,000 people are diagnosed with AML each year. Because acute leukemia may rapidly progress, most AML patients are treated aggressively with chemotherapy drugs. Some patients may require a stem-cell transplant to replace unhealthy bone marrow with leukemia-free stem cells.  

"Abbott's Vysis EGR1 FISH Probe Kit can identify which AML patients have the chromosomal abnormality upon diagnosis and provides physicians with another clinically validated tool to assess a patient's overall prognosis," said Stafford O'Kelly, head of Abbott's molecular diagnostics business.

Published reports from several large clinical studies and the National Comprehensive Cancer Network guidelines suggest that chromosomal abnormalities associated with AML are valuable prognostic indicators. One study, conducted as part of an Eastern Cooperative Oncology Group (ECOG) clinical trial, demonstrated the utility of FISH technology to separate AML patients into risk categories based on chromosomal status or changes. B
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novel New Dog DNA Test Turns Breeders Into Genetic Matchmakers
2. Genetic Profile Identified for Alzheimers Patients Showing Heightened Response to Acceras Breakthrough Product Axona®
3. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
4. American College of Medical Genetics Applauds HHS Secretarys Decision to Expand Newborn Screening to Include Critical Congenital Heart Disease
5. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
6. The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977
7. Genetic Testing Can Help the US Cut Costs and Improve Health Care
8. Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
9. Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
10. Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstage™ GCC Colorectal Cancer Staging Test
11. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... of medical oxygen is vital to any healthcare facility. ... that not only improve the efficiency of its oxygen ... will highlight these systems—including systems for emergency oxygen ... loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... , July 28, 2014 Southern Research ... , Ph.D., President and CEO of Southern Research ... Release Society (CRS) for the 2014-2015 term.  The ... on July 12 in Chicago ... The Controlled Release Society is ...
(Date:7/28/2014)... , July 28, 2014  A prospective ... Sweden has validated the performance ... platforms and has associated volumetrically assessed breast density ... Cancer Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), ... a tool for widespread breast cancer risk assessment," ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
... 2011 Caliper Life Sciences, Inc. (NASDAQ: ... company,s first quarter financial results at 9:00 am Eastern ... Hrusovsky, President and Chief Executive Officer and Peter McAree, ... discuss operational and financial results and the company,s outlook ...
... CARY, N.C., April 20, 2011 Cetero ... (CRO), will present a scientific seminar series for pharmaceutical ... and Conducting an Accelerated Proof-of-Concept Program ." The seminars, ... fall of 2010, will share best practices on how ...
Cached Medicine Technology:Caliper Life Sciences' First Quarter Results Conference Call Notice 2Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies 2Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies 3
(Date:7/28/2014)... of a surgical procedure to treat severe chronic migraine ... percent of the time in patients treated at Massachusetts ... of Plastic and Reconstructive Surgery report that more than ... all of whom had headaches associated with compression ... year later. The team,s paper has received advance ...
(Date:7/28/2014)... Cape Regional Medical Center, is currently ... solution in an effort to streamline its bi-directional ... their New Jersey health information exchange (NJSHINE). , ... New Jersey, serves the local population and more ... inpatient and outpatient services. With a strong commitment ...
(Date:7/28/2014)... MONDAY, July 28, 2014 (HealthDay News) -- Endurance runners ... than an undetected heart condition, according to a new ... athletes participating in events in warm climates are actually ... heat stroke. Yet, the less common sudden death of ... heart problems, such as an irregular heartbeat, often gets ...
(Date:7/28/2014)... 2014 The Oakwood Foundation celebrated a ... Songe and Associates, PC that will benefit each community ... come. , The HBWS group is among the ... $2.5 million in donations. Through their latest gift, they ... Oakwood Women’s Healthcare Classic for the next 6 years; ...
(Date:7/28/2014)... brain was able to arouse animals receiving general anesthesia ... issue of Anesthesiology , investigators from Massachusetts General ... of either agent would move, raise their heads and ... to the ventral tegmental area (VTA). Stimulation of ... not induce the animals to wake up. , ...
Breaking Medicine News(10 mins):Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2
... Dr. Bijan Afar, a well-respected ... Many California residents are now able to benefit from the competent care of Dr. Afar and ... ... to announce the opening of his new office location in North Hollywood. All of the benefits ...
... ... Through Managing Electricity , ... Plano, TX (PRWEB) June 22, 2010 -- Vedero Software, a leading provider ... company Smart Energy Cloud. Under terms of the partnership agreement, Smart Energy Cloud ...
... tendencies until early adulthood, study finds , TUESDAY, June ... outlook are less likely to abuse alcohol, even if they ... Being religious does not, however, appear to prevent such abuse ... are reported in the September issue of Alcoholism: Clinical ...
... ... online medical image cloud computing service, today announced the following organizations will use ... ... June 22, 2010 -- SeeMyRadiology.com ( http://www.SeeMyRadiology.com ), Accelarad’s online medical ...
... ... line of “Eastern” products that address major physiological issues like sleep deprivation, stress, immune ... company,s supplements, oils and creams are comprised of a unique blend of natural ingredients ... ...
... the problem had higher levels of BPA, but study ... (HealthDay News) -- There may be more troubling news ... with polycystic ovary syndrome have higher levels of the ... ovaries of women with polycystic ovary syndrome (PCOS) develop ...
Cached Medicine News:Health News:Trusted Los Angeles Dentist, Dr. Bijan Afar, is Now Practicing in Hollywood Area 2Health News:Trusted Los Angeles Dentist, Dr. Bijan Afar, is Now Practicing in Hollywood Area 3Health News:Vedero Software Announces Partnership with Smart Energy Cloud for Automated Demand Response 2Health News:Vedero Software Announces Partnership with Smart Energy Cloud for Automated Demand Response 3Health News:Accelarad Announces Six New SeeMyRadiology.com Customers Seeking Fast, Secure and Innovative Medical Image Exchange Solution 2Health News:Launching Today: Herbal Destination, a New Kind of Company for Herbal Supplements, Oils and Creams 2Health News:Plastics Chemical BPA May Be Tied to Ovarian Cysts 2Health News:Plastics Chemical BPA May Be Tied to Ovarian Cysts 3
... The NMP22 BladderChek Test is the only in-office ... of bladder cancer. The NMP22 BladderChek Test is ... single urine sample, that detects elevated levels of ... amounts of NMP22 protein in the urine. However, ...
... Kit is a quantitative microplate enzyme immunoassay that ... generally have very small amounts of NMP22 protein ... protein is often elevated in the urine of ... of the disease. The use of the NMP22 ...
... and urethral pressure profilometry. The catheter's ... to be filled while cystometry is ... catheter in the bladder for urodynamic ... standing or sitting. Supplied sterile in ...
... urethral pressure profilometry. Single lumen catheter ... the bladder and more accurate cystometric ... allows the bladder to be filled ... catheter construction allows cystometry and urethral ...
Medicine Products: